Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  WuXi AppTec Plans China IPO
  ShangPharma Plans to Merge CRO/CMO Operations with Public Entity
  C-Bridge Capital and Tasly Invest $150 Million in Two China Biopharmas
  Sihuan Pharma Acquires Ambest Pharma China for $160 Million
  Haoeyou Raises $40 Million for its China-US Mobile Health App
  HitGen to Provide Merck with Drug Leads in New Collaboration
  Medical Device Maker Angiotech Acquired by China Investors
  Tarrex Biopharma, a US-China Startup, Approved to Start US Cancer Drug Trial
  China FDA Proposes New Rules to Speed Foreign Drug Approvals
  Suzhou Ribo Lands $39 Million B Round for siRNA Portfolio
 
Login